Healthcare - Biotechnology - NASDAQ - US
$ 71.76
-6.66 %
$ 1.34 B
Market Cap
-7.83
P/E
CASH FLOW STATEMENT
-111 M
OPERATING CASH FLOW
39 M
INVESTING CASH FLOW
91.9 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Praxis Precision Medicines, Inc.
| Net Income | -123 M |
| Depreciation & Amortization | 432 K |
| Capital Expenditures | -50 K |
| Stock-Based Compensation | 24.9 M |
| Change in Working Capital | -13 M |
| Others | -4.29 M |
| Free Cash Flow | -111 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||
| Net Income | (123.3) | (214.0) | (167.1) | (61.8) | (35.5) | (26.5) |
| Depreciation & Amortization | 0.4 | 0.4 | 0.2 | 50 K | 37 K | 1 K |
| Deferred Income Tax | 0 | 0 | 2.1 | 0 | 0 | 3.6 |
| Stock Based Compensation | 24.9 | 28.6 | 22.7 | 5.2 | 0.7 | 0.6 |
| Other Operating Activities | (0.1) | 1.8 | 1.4 | 0.7 | 0.6 | 0.1 |
| Change in Working Capital | (13.0) | (1.8) | 16.1 | 3.2 | 0.7 | 1.5 |
| Cash From Operations | (111.1) | (185.0) | (124.6) | (52.6) | (33.4) | (20.7) |
| INVESTING CASH FLOW | ||||||
| Capital Expenditures | 50 K | (0.4) | (1.1) | 4 K | (0.1) | 63 K |
| Other Items | 39.0 | 97.3 | (139.5) | 0 | 0 | 0 |
| Cash From Investing Activities | 39.0 | 96.9 | (140.5) | 4 K | (0.1) | 63 K |
| FINANCING CASH FLOW | ||||||
| Common Stock Repurchased | 0 | 0 | 0 | (30.0) | 0 | 0 |
| Total Debt Repaid | 0 | 0 | (0.8) | 0 | 0 | 1.0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0.3 | 0.9 | 2.6 | 103.5 | 60.4 | 36.8 |
| Cash From Financing Activities | 91.9 | 10.5 | 107.6 | 304.4 | 60.4 | 37.8 |
| CHANGE IN CASH | ||||||
| Net Change In Cash | 19.7 | (77.7) | (157.5) | 251.8 | 26.9 | 17.0 |
| FREE CASH FLOW | ||||||
| Free Cash Flow | (111.2) | (185.5) | (125.6) | (52.6) | (33.5) | (20.8) |